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Abstract: Some of the pharmacological properties of spirulina (Spirulina platensis) may be linked to its antioxidant potential, which
mitigates oxidative stresses. In this study we examined whether spirulina mitigated arsenic-induced toxicity in the Black Bengal goat
(Capra hircus). Nonpregnant female goats of approximately 12 months old were used in noninduced, nontreated control (T1); arsenicinduced, nontreated (T2); and arsenic-induced, spirulina-treated (T3) groups. Groups T2 and T3 were given sodium arsenite orally (5 mg/
kg) daily for 15 weeks. For therapeutic justification of spirulina, 1 group of arsenic-treated goats (T3) was given spirulina at 0, 50, 100,
and 150 mg/kg daily for another 15 weeks. At the end of the experiment, the goats were sacrificed. The arsenic-treated goats showed the
highest arsenic accumulation in the kidneys, followed by the liver, lungs, skin, muscles, and heart. Histological analysis demonstrated
fibrosis and lymphocyte infiltration in the liver, degeneration of tubular epithelia and hemorrhage in the kidneys, and keratin deposition
in the skin. IgG- and IgM-bearing lymphocytes were unaffected in arsenic toxicosis. Spirulina treatment did not show any significant
therapeutic effects on arsenic toxicosis in goat. Therefore, spirulina may not be effective in treating arsenic toxicosis in small animals
such as goats.
Key words: Arsenic, spirulina, Black Bengal goat, kidney

1. Introduction
Arsenic toxicity is a global health problem affecting millions
of people. Arsenic is ubiquitous in the environment and
is released from natural and man-made sources (1). At
present, drinking water contamination by arsenic has
been reported from at least 70 countries (2). As arsenic
enters into the food chain, it is possible for a widespread
distribution of arsenic throughout the plant and animal
kingdoms. Goats that graze freely may be exposed to
environmental pollutants like arsenic. Both organic and
inorganic forms of arsenic exist in nature, and while goats
are mainly exposed to inorganic arsenic through drinking
water and feed, they are also exposed to some organic
forms of arsenic through feed. The effects of arsenic
accumulation after long-term intake of low doses to goats
remain obscure. This may possess a potential dietary risk
to humans (3), although little research has focused on goat
meat as an additional source of arsenic exposure. Lowcost sustainable treatment of arsenic intoxication in goats
is currently in demand.
The present knowledge on arsenicosis management
in man and animals is inadequate. So far, there is no
* Correspondence: shafiqpharma@yahoo.co.uk

particular medical treatment that can either prevent or
cure arsenicosis. Knowledge of arsenic metabolism can
be useful in the management of arsenic toxicity in man
and animals. Spirulina (Spirulina platensis), a blue-green
alga, is rich in protein, phytonutrients, antioxidants, and
polysaccharides that might have mitigating effects against
heavy metal poisoning. Spirulina has been recommended
as a chemoprotective against arsenic-induced toxicity
in humans (4,5). It seems reasonable to expect that
administration of spirulina might provide a protective
mechanism against arsenic-induced toxicity in goats.
Thus, the present work was undertaken to determine the
effect of spirulina against arsenic-induced toxicity in Black
Bengal goats (Capra hircus).
2. Materials and methods
Experiments were carried out at the Department of
Pharmacology, Bangladesh Agricultural University,
Mymensingh, Bangladesh. A completely randomized
design was used in this work. All works were performed
according to the ethics of laboratory animal use.

63

GHOSH et al. / Turk J Vet Anim Sci
2.1. Animals
Twenty-four clinically healthy, nonpregnant Black Bengal
female goats (Capra hircus) at the age of approximately
12 months and weighing 10–12 kg were used. They were
housed in groups in a well-ventilated shed on wooden slats
and were acclimatized to the environment for 2 months.
Goats were dewormed by subcutaneous injection with
nitroxynil (Nitronex, Renata Animal Health, Dhaka,
Bangladesh) at 10 mg/kg and ivermectin (Acimec 1%
vet, ACI Ltd., Dhaka, Bangladesh) at 0.2 mg/kg and were
vaccinated against peste des petits ruminants (Livestock
Research Institute, Dhaka, Bangladesh). Complete
deworming was confirmed by evaluating fresh manure
monthly by modified McMaster fecal egg counting test.
Animals were kept on pasture daily between 0900 and 1600
hours and were supplemented with 200 g of concentrate
daily along with ad libitum tube well water. Goats were
grouped randomly into 3 treatment groups: noninduced,
nontreated control (T1, n = 4); arsenic-induced, nontreated
(T2, n = 4); and arsenic-induced, spirulina-treated (T3, n =
16) groups. Subchronic arsenic toxicosis was developed in
each goat of T2 and T3 by administering sodium arsenite
(pro analysis grade, Merck, Germany) at 5 mg/kg daily for
15 weeks orally. T1 goats were given 5 mL of distilled water
as a vehicle daily for 15 weeks. At the end of 15 weeks, T3
was further divided into 4 equal subgroups (T3-i, T3-ii, T3-iii,
and T3-iv). Spirulina was fed to T3-ii, T3-iii, and T3-iv at 50, 100,
and 150 mg/kg daily, respectively, for another 15 weeks with
gelatin and sucrose. Subgroup T3-i being a positive control,
received gelatin and sucrose daily as a placebo. Goats were
observed daily for noticeable changes in feed and water
consumption and signs of disease, and the condition(s)
were recorded. At the end of the experiment the goats
were euthanized with sodium pentobarbitone. Just after
euthanasia, the liver, kidneys, lungs, thigh muscles, heart,
skin (from neck region), femur, and prefemoral lymph
nodes were harvested in physiological saline. For arsenic
determination, aliquots of the liver, kidneys, lungs, thigh
muscles, skin, heart, and femur were stored at –20 °C.
For immunochemical analysis and histopathological
examination, pieces of liver, kidney, skin, and prefemoral
lymph node were fixed in 10% neutral buffered formalin.
2.2. Preparation of samples for detection of arsenic level
by atomic absorption spectrophotometer
All reagents were of analytical grade. Millipore water
was used throughout. Tissues were acid-digested in a
block digester (M-24 plazas/samples, JP Selecta, Spain)
according to procedures outlined by Cox (6) with minor
modifications. Briefly, 1.5–2.5 g of tissue (wet wt., w/w)
was taken in a digestion tube and digested by heating
up to 150 °C, sequentially adding 5–7.5 mL of triple acid
mixture (nitric acid - 10 parts, perchloric acid - 3 parts, and
sulfuric acid - 1 part) and 3 mL of 30% hydrogen peroxide.
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To validate the assay, 1 blank and 1 standard reference
material (SRM) were prepared after every 15 samples.
Concentrations of total arsenic (inorganic plus organic)
in digested samples were determined using an atomic
absorption spectrophotometer coupled with a hydride
generator (PG Instruments Ltd., UK). The detection limit
was 2 µg/L. Quantification of arsenic was performed by
spiking samples with working standards of 0, 2.5, 5, 10,
15, and 20 µg/L, prepared immediately before use by serial
dilution of the stock (arsenic pentoxide, Merck, Germany;
1,000,000 µg/L) in 10% hydrochloric acid. The salient
features, instrument settings, and carriers were as follows:
light source - ordinary hollow-cathode lamp; carrier
gas - pure argon; carrier liquid - 1% hydrochloric acid;
wavelength - 193.7 nm. Accuracy and precision of analyses
were evaluated using commercially available SRMs from
the National Institute of Standards and Technology (NIST),
USA, with certified arsenic concentrations [NIST 1577b
(bovine liver 47 ± 5 µg/kg, recovery rate 85%–103%)].
There was good conformity between obtained arsenic
concentrations in the SRM and the reference values.
2.3. Histopathology
Formaldehyde-fixed tissues were processed through
conventional histological procedures, cut into 5-µmthick sections, and stained with routine hematoxylin
and eosin (H&E). Immunostaining was performed as
previously described (7) with few modifications. Briefly,
prefemoral lymph nodes were cut into 5-µm sections from
paraffin blocks and placed on silanized slides. Slides were
deparaffinized and rehydrated, and antigen was unmasked
using Tris/EDTA buffer (pH 9.0) at 95 °C for 4–5 min. The
endogenous peroxidase activity was blocked by soaking
the slides in 0.3% H2O2 in Tris-buffered saline (pH 7.4)
for 15 min at room temperature. To reduce nonspecific
background staining, slides were treated with 4% fetal
calf serum at 37 °C for 45 min. Secondary antibody [for
IgG - rabbit antigoat IgG labeled with HRP (Bangalore
Genei, India), 1:1000 dilutions; for IgM - antigoat IgM
(Rockland Immunochemicals, Gilbertsville, PA, USA),
1:100 dilutions] was applied and incubated at 37 °C for
45 min. Peroxidase conjugated affinity purified antirabbit
IgG (H&L, Goat; Rockland Immunochemicals) at 1:1000
dilutions was also added for detecting IgM-bearing
lymphocytes and reincubated at 37 °C for 45 min. A
chromogen, 3-3’-diaminobenzidine tetrahydrochloride
(DAB) (Bangalore Genei), was applied and incubated at
room temperature in the dark for 10 min. Incubations
were carried out in a humidified chamber to avoid drying
the tissue. Between every step, slides were washed 3
times with PBS (pH 7.4) for 5 min each. In every batch,
a negative control section was tested using PBS instead of
a secondary antibody. Sections were counterstained with
Harris’s hematoxylin. Clear immunostaining under a light
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to the control. Incorporation of spirulina did not show any
significant (P > 0.05) effects on the diminution of arsenic
from tissues.
3.2. Histopathological findings
Light microscopic examination of the livers of the control
(T1) goats did not show any pathology (Figure 1). The
arsenic-treated (T2) goats showed noncirrhotic portal
fibrosis characterized by expansion of portal zones
with streaky fibrous tissue proliferation, lymphocytic
infiltration at the periphery of portal zone, and, in a few
cases endothelial cell degeneration. Increased pyknotic
nuclei of hepatocytes and drop-out necrosis were visible
in focal areas and there was formation of syncytia.
Nonsupplemented arsenic-induced control and spirulinasupplemented goats showed expanded portal zones with
portal fibrosis, but there were fewer pyknotic nuclei in
hepatocytes and lymphocyte infiltration.
We then examined tissues of the kidneys, vital organs
of the body, to determine whether they were affected by
exposure to arsenic poisoning. The control goats (T1)
did not display any histopathological changes (Figure 2).
Arsenic-treated goats (T2) showed mild to severe necrosis
and degenerative changes. Hydropic degeneration of
tubular epithelia and especially of proximal tubules,
proteinaceous casts as evidenced by pink color masses in
the tubules, and pyknotic nuclei of the tubular epithelia
in arsenic-treated goats (T2) were noticed. The epithelial
cells around the renal blood vessels showed necrosis and
damage, indicated by the presence of fibrosis replacing the
damaged areas. Bowman’s capsular spaces were expanded
due to the shrinkage of the glomerular cells. There were
profuse hemorrhages in the medulla, indicative of

microscope (600×) was interpreted as a positive staining
result for IgG and IgM.
2.4. Statistical analysis
Data were analyzed using SPSS (SPSS Inc., Chicago, IL,
USA). Treatment-related differences in arsenic residues in
the tissues were determined using the independent samples
t-test between 2 groups, while multiple comparisons of
means were performed using the F-test with a significance
level of P < 0.05 (8).
3. Results
3.1. Arsenic residue in tissues
The presence of arsenic (w/w) in the tissues were
determined by atomic absorption spectrophotometer and
is presented in the Table. Only a small amount of arsenic
was found in tissues (w/w) of the control goats, with the
highest distribution in the liver (186.3 ± 15.9 µg/kg).
Fifteen weeks of successive sodium arsenite treatment
resulted in significant (P < 0.01) elevations of several fold of
arsenic (µg/kg) in all tissues compared to the control, with
the highest distribution in the kidneys (2272.3 ± 100.3),
followed by the liver (1726.0 ± 100.3), lungs (1309.3 ±
60.6), skin (1222.5 ± 94.5), thigh muscles (1093.3 ± 85.5),
and heart (977.3 ± 62.7). Significant (P < 0.01) elevation
of arsenic residue in bones (dry weight) of arsenic-treated
goats (2486.0 ± 299.4 µg/kg) was observed as compared to
the control (523.8 ± 59.9 µg/kg). At the end of spirulina
supplementation, arsenic residues in tissues reverted to
close to the pretreatment state, irrespective of employing
spirulina. However, significantly (P < 0.05) greater arsenic
in the bone of nonsupplemented arsenic-induced control
and spirulina-supplemented goats were found as compared

Table. Residual concentration of arsenic in wet tissue following 15 weeks of oral administration of sodium arsenite (5 mg/kg) or spirulina
in sodium arsenite-treated goats. Values are means ± SEMs.
Arsenic concentration (µg/kg)
Sodium arsenite treatment

Spirulina supplementation †

Control goats

Arsenic-induced goats

Nonsupplemented
goats

Supplemented goats
50 mg/kg

100 mg/kg

150 mg/kg

Liver

186.3 ± 15.9

1726.0 ± 100.3**

139.0 ± 19.8

145.5 ± 16.7

135.0 ± 21.3

139.8 ± 28.2

Kidneys

126.3 ± 9.5

2272.3 ± 100.3**

161.0 ± 18.8

165.5 ± 32.5

125.3 ± 36.9

147.8 ± 22.3

Lungs

124.3 ± 15.5

1309.3 ± 60.6

116.8 ± 22.9

109.0 ± 26.4

122.8 ± 27.9

108.8 ± 22.2

101.5 ± 19.1

103.5 ± 26.8

120.3 ± 24.0

ac

136.3 ± 5.2

151.0 ± 30.1

192.3 ± 30.6

114.5 ± 15.0bc

132.5 ± 16.8

139.8 ± 19.6

148.5 ± 19.9

133.0 ± 7.2

842.3 ± 71.7

992.3 ± 78.7

993.8 ± 36.2

893.0 ± 132.0

Organ/tissues

**

Heart muscles 106.5 ± 6.3

977.3 ± 62.7**

Thigh muscles 118.3 ± 9.7

1093.3 ± 85.5

Skin

125.0 ± 7.4

1222.5 ± 94.5

523.8 ± 59.9

2486.0 ± 299.4

Bones

‡

**
**
**

ac

102.0 ± 19.3
a

: Significant difference (P < 0.01) between control and arsenic-treated groups.
: Any 2 means in a row having different superscripted letters differ significantly at a 5% level of probability after spirulina supplementation.
‡
: Values in dry-weight basis.
**
†
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Histopathology of Liver
Control

Control (+)

Spirulina 100 mg/kg

Arsenic - treated

Spirulina 50 mg/kg

Spirulina 150 mg/kg

Figure 1. Histopathology of goat liver. T1: Control, showing no change in hepatocytes. T2: Sodium arsenitetreated (5 mg/kg orally daily for 15 weeks); pathological changes showing expansion of portal zones with
streaky fibrosis, periportal lymphocytic infiltration, and endothelial cell degeneration. After 15 weeks, arsenic
was terminated and the arsenic-treated animals were supplemented with spirulina at different doses (15 weeks),
where 1 group was kept as the positive control (without spirulina). T3-I: Control (+); T3-ii: spirulina at 50 mg/
kg; T3-iii: spirulina at 100 mg/kg; T3-iv: spirulina at 150 mg/kg; histopathological lesions in control (+) and all
spirulina-fed groups depicting expansion of portal zones with portal fibrosis, lesser than in T2 (H&E, 100× for
all panels).

glomerular damage. In nonsupplemented arsenic-induced
control and spirulina-supplemented goats (T3-ii, T3-iii, and
T3-iv), degenerative lesions of the convoluted tubules were
improved, indicated by regular cellular arrangement,
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absence of proteinaceous casts in the tubules, and few
pyknotic nuclei of the tubular epithelia. Bowman’s space
recovered, but in a few cases, glomerular cells proliferated.
The recovery was better in spirulina-supplemented groups

GHOSH et al. / Turk J Vet Anim Sci
Histopathology of Kidney
Control

Control (+)

Spirulina 100 mg/kg

Arsenic - treated

Spirulina 50 mg/kg

Spirulina 150 mg/kg

Figure 2. Histopathology of goat kidney. T1: Control, showing normal Bowman`s capsule and kidney tubules. T2:
Sodium arsenite-treated (5 mg/kg orally daily for 15 weeks); pathological changes showing hydropic degeneration
of tubular epithelia, expanded Bowman`s capsular space, and hemorrhage in the medulla. After 15 weeks, arsenic
was terminated and the arsenic-treated animals were supplemented with spirulina at different doses (15 weeks),
where 1 group was kept as the positive control (without spirulina). T3-I: Control (+); T3-ii: spirulina at 50 mg/kg;
T3-iii: spirulina at 100 mg/kg; T3-iv: spirulina at 150 mg/kg; histopathological lesions in control (+) and all spirulinafed groups depicting few pyknotic nuclei of tubules and proliferated glomerular cells (H&E, 100× for all panels).

as compared to the nonsupplemented arsenic-induced
control.
The skin is also a target organ for arsenic deposition,
and changing of the skin structure would be an interesting
finding in this study. Our histopathological analysis

is shown in Figure 3. Skin of the control goats was
normal. In arsenic-treated (T2) goats, mild thickening of
the cornified layer of the epidermis was observed. The
papillary cells proliferated, giving increased numbers of
papillary fibroblasts. Mild infiltration of lymphocytes
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Histopathology of Skin
Control

Spirulina 50 mg/ kg

Arsenic -treated

Spirulina 100 mg/ kg

Control (+)

Spirulina 150 mg/ kg

Figure 3. Histopathology of goat skin. T1: Control, showing thin keratin layer with normal hair follicles. T2: Sodium
arsenite-treated (5 mg/kg orally daily for 15 weeks); pathological changes showing mild thickening of the cornified
layer of the epidermis, proliferated papillary cells, and cystic appearance of the follicles. After 15 weeks, arsenic was
terminated and the arsenic-treated animals were supplemented with spirulina at different doses (15 weeks), where 1
group was kept as the positive control (without spirulina). T3-i: Control (+); T3-ii: spirulina at 50 mg/kg; T3-iii: spirulina
at 100 mg/kg; T3-iv: spirulina at 150 mg/kg; histopathological lesions in control (+) and all spirulina-fed groups
depicting gentle proliferation of follicular cells and few cystic appearances of follicles (H&E, 100× for all panels).

and neutrophils was observed in the papillary areas.
Numbers of follicular cells were increased. Some of the
follicles were atrophied and there was destruction of
some follicles, giving cystic appearance. Fifteen weeks
after arsenic withdrawal, the histopathological sections of
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nonsupplemented arsenic-induced control and spirulinasupplemented goats revealed mild thickening of the
keratin layer (stratum corneum) and mild proliferation
of follicular cells. Cystic appearances of hair follicles, as
in the arsenic-treated (T2) group, remained constant.
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Accumulations of a few lymphocytes were observed
in the papillary layer of the dermis. No difference was
observed in histopathological sections of skin between
nonsupplemented arsenic-induced control and spirulinasupplemented goats or within spirulina-supplemented
groups. The cutaneous manifestations of chronic arsenic
poisoning have an insidious onset.
3.3. Immunohistochemical evaluations of IgG- and IgMbearing lymphocytes
Any poisoning, whether subacute or chronic exposure,
may have some influences directly or indirectly on
the immune system of the body. Lymphocytes are an
indication of the body’s immune system in general
phenomena. We investigated whether arsenic exposure
in goats influences the immune system. Sodium arsenite
treatment to the goats did not significantly alter the IgGbearing lymphocytes in the lymph nodes compared to the
control (Figure 4). The control goats showed 86.0 ± 3.0%
IgG-positive lymphocytes, whereas the corresponding
value was 81.8 ± 1.1% for arsenic-treated (T2) goats.
Supplementation of spirulina to arsenic-treated goats did
not significantly (P > 0.05) modify the IgG-positive to IgGnegative lymphocyte ratio. IgM staining of lymph nodes
showed 15.7 ± 1.5% positive lymphocytes in the control
and 15.0 ± 0.5% in arsenic-treated (T2) goats (Figure 5).
Spirulina supplementation did not alter the IgM-positive
lymphocytes in the lymph node. Arsenic has been
recognized as a powerful immunomodulatory agent in
many laboratory animals and in epidemiological studies.
4. Discussion
Our atomic absorption spectrophotometric evaluation
showed low amounts of arsenic presence in the tissues
of the control goats. However, 15 weeks of successive
sodium arsenite treatment resulted in significant elevation
of arsenic in all tissues as compared with the noninduced
control. At the end of spirulina supplementation, arsenic
residues in tissues reverted to close to the pretreatment
state. It is to be mentioned that arsenic-induced nontreated
control goats also reverted to close to the pretreatment
state. Moreover, both supplemented and nonsupplemented
spirulina showed significantly greater arsenic residue in
the bone tissues. Goats did not show any clinical signs of
arsenic toxicity. This may be due to the small dose and/
or short duration of treatment. Arsenic is a slow poison
and symptoms of arsenic poisoning develop only after
prolonged consumption. The presence of arsenic in tissues
of the control goats may be due to the consumption of food
and water contaminated with traces of this element, which
is universally distributed in Bangladesh (9). Accumulation
of high arsenic residues in tissues of arsenic-treated goats
may be due to repeated doses. Different concentrations of
arsenic in different tissues indicate different distributions

(10). The highest arsenic residue in the kidneys of arsenictreated goats is consistent with earlier findings (11). These
metabolites and unchanged arsenic might accumulate in
kidney tissues. Depletion of arsenic residue in tissues of
nonsupplemented arsenic-induced control goats to the
pretreatment state indicates self-detoxification by goats, or
antioxidants in green grass may, at least in part, help to
eliminate arsenic. However, the antioxidant role of green
grass has not been proven to warrant further study. Higher
arsenic residues in bone indicate its slower elimination
from bone than other soft tissues.
Light microscopic examination of the livers of the
control goats did not show any pathology. The arsenictreated goats showed noncirrhotic portal fibrosis
characterized by expansion of portal zones with streaky
fibrous tissue proliferation. Periportal lymphocytic
infiltration and endothelial cell degeneration were
visible in a few cases. Both spirulina-supplemented and
nonsupplemented groups showed expanded portal zones
with portal fibrosis, but there were fewer pyknotic nuclei
in hepatocytes and less periportal lymphocytic infiltration.
The liver appeared to be a major organ of arsenic toxicity,
possibly because of its unique vasculature as well as
generation of potentially toxic metabolites. Chronic
administration of inorganic arsenic to experimental
animals produced various liver lesions in a dosedependent manner, including inflammation and oxidative
damage (12), ballooning of hepatocytes with lymphocytic
infiltration in the periportal as well as parenchymal area,
and drop-out necrosis. Increased pyknotic nuclei of
hepatocytes in arsenic-treated goats are an indication of
cellular necrosis. Arsenic exerts oxidative stress that results
in depletion of the cellular endogenous antioxidant reserve,
which leads to apoptosis (13). Due to its lipophilic nature,
arsenic attaches to lipid, inducing lipid peroxidation that
causes the deposition of lipid droplets in tissues; little or
no such change may be due to low-fat diet and/or short
duration of the experiment. Endothelial cell degeneration
may be a consequence of direct effects of arsenic-induced
inflammation on the vascular cells and indirect effects on
the liver vasculature.
The kidneys of the control goats did not display any
histopathological changes. Arsenic-treated goats showed
mild to severe necrosis and degenerative changes.
Hydropic degeneration of tubular epithelia and especially
of proximal tubules, proteinaceous casts as evidenced by
pink color masses in the tubules, and pyknotic nuclei of
the tubular epithelia in arsenic-treated goats were noticed.
The epithelial cells around the renal blood vessels were
necrotized and damaged, as indicated by the presence
of fibrosis replacing the damaged areas. Bowman’s
capsular spaces were expanded due to the shrinkage of
the glomerular cells. There were profuse hemorrhages in
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Histopathology of Lymph node for IgG lymphocyte
A
Control

Arsenic - treated

(b)
90
% IgG positive
lymphocytes

(a)

B
(a)

85
80
75
Control

Control (+)

Spirulina 50 mg/kg

As treated

(b)

Spirulina 100 mg/kg

Spirulina 150 mg/kg

% IgG positive lymphocytes

90

85

80

75
Control
(+)

50

100

150

Spirulina (mg/kg)

Figure 4. Immunohistochemical evaluation of IgG-bearing lymphocytes in the lymph nodes of goats. Animals were
subjected to sodium arsenite treatment (5 mg/kg orally daily for 15 weeks). A(a): Immunohistochemical analysis
photographs, T1, untreated control, and T2, sodium arsenite-treated. Arrow indicates IgG-positive lymphocytes (600× for
both panels). A(b): Graphical representation of percentage (mean + SEM) of IgG-bearing lymphocytes in each group (n =
3 for each group). B: After 15 weeks of exposure, arsenic was stopped and the animals were supplemented with spirulina
for another 15 weeks. B(a): T3-i, control (+) (without spirulina); T3-ii, T3-iii, and T3-iv were treated with 50 mg, 100 mg, and
150 mg spirulina/kg body weight, respectively. Arrow indicates IgG-positive lymphocytes (600× for all panels). B(b):
Graphical representation of percentage (mean + SEM) of IgG-bearing lymphocytes in each group (n = 3 for each group).

the medulla, indicative of glomerular damage. Both in
spirulina-supplemented and nonsupplemented groups,
degenerative lesions of the convoluted tubules were
improved, indicated by regular cellular arrangement,
absence of proteinaceous casts in the tubules, and few
pyknotic nuclei of the tubular epithelia. Bowman’s space
recovered, but in a few cases, glomerular cells proliferated.
The recovery was better in spirulina-supplemented groups
than the nonsupplemented group. The urinary system
and especially the kidneys and bladder are considered the
second target organs of arsenic toxicity. Bowman’s capsule
and the epithelial cells of proximal convoluted tubules of
the kidneys are sensitive to arsenic (14,15).
In arsenic-treated goats, mild thickening of the
cornified layer of the epidermis was observed. The
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papillary cells proliferated, giving an increased number of
papillary fibroblast. Mild infiltration of lymphocytes and
neutrophils were observed in the papillary areas. Numbers
of follicular cells were increased. Some of the follicles were
atrophied and there was destruction of some follicles,
giving a cystic appearance. Fifteen weeks after arsenic
withdrawal, the histopathology of spirulina-supplemented
and nonsupplemented groups revealed mild thickening of
the keratin layer (stratum corneum) and mild proliferation
of follicular cells. Cystic appearances of hair follicles,
as in the arsenic-treated group, remained constant.
Accumulations of a few lymphocytes were observed
in the papillary layer of the dermis. No difference was
observed in the histopathology sections of skin between
spirulina-supplemented and nonsupplemented groups or
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Histopathological analysis of Lymph node for IgM lymphocyte
A
(a)

(b)
Arsenic-treated
% IgM positive
lymphocytes

Control

20
15
10
5
0

Control (+)

Spirulina 100 mg/kg

Spirulina 50 mg/kg

Spirulina 150 mg/kg

Control

As treated

(b)
20
% IgM positive lymphocytes

B
(a)

15

10

5

0
Control (+)

50

100

150

Spirulina (mg/kg)

Figure 5. Immunohistochemical evaluation of IgM-bearing lymphocytes in the lymph nodes of goats. Animals were subjected
to sodium arsenite treatment (5 mg/kg orally daily for 15 weeks). A(a): immunohistochemical analysis photographs, T1,
untreated control, and T2, sodium arsenite-treated. Arrow indicates IgG-positive lymphocytes (600× for both panels). A(b):
Graphical representation of percentage (mean + SEM) of IgG-bearing lymphocytes in each group (n = 3 for each group). B:
After 15 weeks of exposure, arsenic was stopped and the animals were supplemented with spirulina for another 15 weeks.
B(a): T3-i, control (+) (without spirulina); T3-ii, T3-iii, and T3-iv were treated with 50 mg, 100 mg, and 150 mg spirulina/kg
body weight, respectively. Arrow indicates IgG positive lymphocytes (600× for all panels). B(b): Graphical representation of
percentage (mean + SEM) of IgG-bearing lymphocytes in each group (n = 3 for each group).

within spirulina-supplemented groups. The cutaneous
manifestations of chronic arsenic poisoning have an
insidious onset. Predominant skin lesions in humans
are hyperkeratosis, parakeratosis, acanthosis, and
papillomatosis (16). Hyperkeratosis and thickening of the
stratum corneum in the skin of arsenic-treated goats is in
line with that seen in humans (17). This finding supports
the hypothesis that arsenic exposure causes chronic
stimulation of keratinocyte-derived growth factors that
act to facilitate skin cancer by serving as co-promoters.
Destruction of hair follicles in arsenic-treated goats
demonstrates that hair follicles are the predilection site
of arsenic. However, milder skin lesions than in humans
may be due to unexposed areas and short durations of
treatment.
Sodium arsenite treatment to the goats did not
significantly alter the IgG-bearing lymphocytes in the

lymph node as compared to the control. Supplementation
of spirulina to arsenic-treated goats did not significantly
modify the IgG-positive to IgG-negative lymphocyte
ratio or the IgM-positive lymphocytes in the lymph
node. Arsenic has been recognized as a powerful
immunomodulatory agent in many laboratory animals
and in epidemiological studies (18). However, the
insignificant effect of spirulina on immune functions in
the present study might be due, in part, to large intake of
green grass, which might provide more micronutrients
and antioxidants than the small amount of spirulina.
The present study determined that low, subchronic
treatment with sodium arsenite in goats resulted in the
accumulation of arsenic in tissues, which moderately
altered the architecture of tissues but did not affect the
IgG- and IgM-bearing lymphocytes. Spirulina showed
very little effect on the repair of arsenic-induced lesions
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in goats. Rapid restoration of body functions in arsenicinduced goats may be due, at least in part, to the rapid
detoxifying capacity of arsenic in goats and/or the
antioxidant role of green grass. Additional laboratory
studies with chronic higher doses of arsenic and the role
of green grass in reducing the effects of arsenic toxicities
in goats need to be assessed to substantiate these
suggestions.
Over all, spirulina supplementation did not
demonstrate any significant therapeutic effects in arsenicinduced toxicities in the Black Bengal goat. Therefore,

spirulina may not be effective in treating arsenic toxicosis
in small animals such as goats.
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